Annji Pharmaceutical Co (ROCO:7754) Total Long-Term Liabilities: NT$167.51 Mil (As of Dec. 2025)


ROCO:7754 Annji Pharmaceutical Co Ltd ROCO:7754
9 GF Score
Price NT$60.00
! 3 Warning Signs
View Full Analysis

What is Annji Pharmaceutical Co Total Long-Term Liabilities?

Annji Pharmaceutical Co ROCO:7754 +0.67% 9 Total Long-Term Liabilities is NT$167.51 Mil as of Dec. 2025. GuruFocus rates ROCO:7754 with a GF Score™ of 9/100. The stock has 3 warning signs investors should review.

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Annji Pharmaceutical Co's Total Long-Term Liabilities for the quarter that ended in Dec. 2025 was NT$167.51 Mil.

Annji Pharmaceutical Co Total Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Annji Pharmaceutical Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annji Pharmaceutical Co Total Long-Term Liabilities Chart

Annji Pharmaceutical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Liabilities
0.16 0.00 55.34 49.36 167.51

Annji Pharmaceutical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Long-Term Liabilities Get a 7-Day Free Trial 55.34 52.37 49.36 164.71 167.51
ROCO:7754
9GF Score
Annji Pharmaceutical Co Ltd ROCO:7754
Total Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Annji Pharmaceutical Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

What does a Total Long-Term Liabilities of NT$167.51 Mil mean?
Annji Pharmaceutical Co (ROCO:7754) has a Total Long-Term Liabilities of NT$167.51 Mil as of Dec. 2025. Toal Long-Term Liabilities is the obiligation expected to be repaid beyond the following twelve months or one business cycle. View historical data on Annji Pharmaceutical Co and its competitors.
Is Annji Pharmaceutical Co's Total Long-Term Liabilities too high?
Annji Pharmaceutical Co's current Total Long-Term Liabilities is NT$167.51 Mil. Overall, Annji Pharmaceutical Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Annji Pharmaceutical Co's Total Long-Term Liabilities compare to VRTX and REGN?
Annji Pharmaceutical Co's Total Long-Term Liabilities of NT$167.51 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Liabilities for a Biotechnology company?
A good Total Long-Term Liabilities depends on the Biotechnology industry context. However, Total Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Liabilities mean?
A high Total Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Toal Long-Term Liabilities is the obiligation expected to be repaid beyond the following twelve months or one business cycle. View historical data on Annji Pharmaceutical Co and its competitors. Annji Pharmaceutical Co's current Total Long-Term Liabilities is NT$167.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annji Pharmaceutical Co stock overvalued right now?
Annji Pharmaceutical Co (ROCO:7754) has a current Total Long-Term Liabilities of NT$167.51 Mil. The current Total Long-Term Liabilities is NT$167.51 Mil. Annji Pharmaceutical Co's overall GF Score™ is 9/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Liabilities calculated?
Total Long-Term Liabilities is calculated from a company's financial statements. For Annji Pharmaceutical Co (ROCO:7754), the current Total Long-Term Liabilities is NT$167.51 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Annji Pharmaceutical Co Business Description

Address Zhongxiao E. Raod, 16th Floor-6, No. 508, Sector 7, Nangang Distrist, Taipei, TWN, 115011
Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.
9GF Score

Get the complete analysis for ROCO:7754

Total Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$60.00
Price